Curegenix Corporation
1 known investors
Find your way into Curegenix Corporation
Sign up to see every warm intro you have to Curegenix Corporation
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curegenix Corporation team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.
Investors · 1
Frequently asked questions
- What does Curegenix Corporation do?
- Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.
- Who are Curegenix Corporation's investors?
- Curegenix Corporation's investors include F-Prime Capital.